Cytokinetics (CYTK) Price to Sales (2010 - 2026)
Powered by 
Analysis
Cytokinetics (CYTK) Price to Sales (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cytokinetics | 9.63 Bn | 8.46 Bn | 25.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 413.76 |
| Mar 31, 2026 | 423.73 |
| Dec 31, 2025 | 439.98 |
| Sep 30, 2025 | 3,470.91 |
| Jun 30, 2025 | 59.21 |
| Mar 31, 2025 | 3,039.76 |
| Dec 31, 2024 | 370.70 |
| Sep 30, 2024 | 13,458.21 |
| Jun 30, 2024 | 25,601.59 |
| Mar 31, 2024 | 8,803.96 |
| Dec 31, 2023 | 5,075.21 |
| Sep 30, 2023 | 7,481.75 |
| Jun 30, 2023 | 3,611.83 |
| Mar 31, 2023 | 729.59 |
| Dec 31, 2022 | 2,220.38 |
| Sep 30, 2022 | 1,823.01 |
| Jun 30, 2022 | 41.58 |
| Mar 31, 2022 | 2,746.39 |
| Dec 31, 2021 | 69.52 |
| Sep 30, 2021 | 551.40 |